UXT-V1 facilitates the formation of MAVS antiviral signalosome on mitochondria

Journal of Immunology

Volumn 188, Issue 1, 2012, Pages 358-366

  Huang, Yuefeng ^a   Liu, Heng ^a   Ge, Rui ^a   Zhou, Yi ^a   Lou, Xiwen ^a   Wang, Chen ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; MAVS SIGNALOSOME; MITOCHONDRIAL PROTEIN; PROTEIN UXT V1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MITOCHONDRION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; TRANSCRIPTION INITIATION; VIRUS CELL INTERACTION; VIRUS INFECTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID MOTIFS; ANIMALS; HEK293 CELLS; HELA CELLS; HUMANS; INTERFERON REGULATORY FACTOR-3; INTERFERON-BETA; MICE; MITOCHONDRIA; MOLECULAR CHAPERONES; NEOPLASM PROTEINS; NF-KAPPA B; NIH 3T3 CELLS; PROTEIN BINDING; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 3; VIRUS DISEASES;

EID: 84855402663     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102079     Document Type: Article

References (41)

1. Janeway, C. A., Jr. 1989. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 54: 1-13.
2. Medzhitov, R., and C. A. Janeway, Jr. 1998. Innate immune recognition and control of adaptive immune responses. Semin. Immunol. 10: 351-353. (Pubitemid 28499548)
3. Meylan, E., and J. Tschopp. 2006. Toll-like receptors and RNA helicases: two parallel ways to trigger antiviral responses. Mol. Cell 22: 561-569. (Pubitemid 43817607)
4. Uematsu, S., and S. Akira. 2006. Toll-like receptors and innate immunity. J. Mol. Med. 84: 712-725. (Pubitemid 44328063)
5. Yoneyama, M., and T. Fujita. 2008. Structural mechanism of RNA recognition by the RIG-I-like receptors. Immunity 29: 178-181.
6. Kawai, T., and S. Akira. 2008. Toll-like receptor and RIG-I-like receptor signaling. Ann. N. Y. Acad. Sci. 1143: 1-20.
7. Sun, L., S. Liu, and Z. J. Chen. 2010. SnapShot: pathways of antiviral innate immunity. Cell 140: 436-436.e2.
8. Seth, R. B., L. Sun, C. K. Ea, and Z. J. Chen. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122: 669-682. (Pubitemid 41242633)
9. Kawai, T., K. Takahashi, S. Sato, C. Coban, H. Kumar, H. Kato, K. J. Ishii, O. Takeuchi, and S. Akira. 2005. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 6: 981-988. (Pubitemid 41486182)
10. Meylan, E., J. Curran, K. Hofmann, D. Moradpour, M. Binder, R. Bartenschlager, and J. Tschopp. 2005. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437: 1167-1172. (Pubitemid 41509355)
11. Xu, L. G., Y. Y. Wang, K. J. Han, L. Y. Li, Z. Zhai, and H. B. Shu. 2005. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol. Cell 19: 727-740. (Pubitemid 41316668)
12. Oganesyan, G., S. K. Saha, B. Guo, J. Q. He, A. Shahangian, B. Zarnegar, A. Perry, and G. Cheng. 2006. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature 439: 208-211. (Pubitemid 43083142)
13. Michallet, M. C., E. Meylan, M. A. Ermolaeva, J. Vazquez, M. Rebsamen, J. Curran, H. Poeck, M. Bscheider, G. Hartmann, M. König, et al. 2008. TRADD protein is an essential component of the RIG-like helicase antiviral pathway. Immunity 28: 651-661.
14. Honda, K., A. Takaoka, and T. Taniguchi. 2006. Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity 25: 349-360. (Pubitemid 44354220)
15. Hiscott, J. 2007. Triggering the innate antiviral response through IRF-3 activation. J. Biol. Chem. 282: 15325-15329. (Pubitemid 47093257)
16. Yoneyama, M., and T. Fujita. 2010. Recognition of viral nucleic acids in innate immunity. Rev. Med. Virol. 20: 4-22.
17. Hiscott, J. 2007. Convergence of the NF-kappaB and IRF pathways in the regulation of the innate antiviral response. Cytokine Growth Factor Rev. 18: 483-490. (Pubitemid 47302822)
18. Balachandran, S., E. Thomas, and G. N. Barber. 2004. A FADD-dependent innate immune mechanism in mammalian cells. Nature 432: 401-405. (Pubitemid 39551675)
19. Saha, S. K., E. M. Pietras, J. Q. He, J. R. Kang, S. Y. Liu, G. Oganesyan, A. Shahangian, B. Zarnegar, T. L. Shiba, Y. Wang, and G. Cheng. 2006. Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif. EMBO J. 25: 3257-3263. (Pubitemid 44141784)
20. Ishikawa, H., and G. N. Barber. 2008. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455: 674-678.
21. Moore, C. B., D. T. Bergstralh, J. A. Duncan, Y. Lei, T. E. Morrison, A. G. Zimmermann, M. A. Accavitti-Loper, V. J. Madden, L. Sun, Z. Ye, et al. 2008. NLRX1 is a regulator of mitochondrial antiviral immunity. Nature 451: 573-577. (Pubitemid 351186265)
22. Liu, X. Y., B. Wei, H. X. Shi, Y. F. Shan, and C. Wang. 2010. Tom70 mediates activation of interferon regulatory factor 3 on mitochondria. Cell Res. 20: 994-1011.
23. Wang, C., X. Liu, and B. Wei. 2011. Mitochondrion: an emerging platform critical for host antiviral signaling. Expert Opin. Ther. Targets 15: 647-665.
24. Zhong, B., Y. Yang, S. Li, Y. Y. Wang, Y. Li, F. Diao, C. Lei, X. He, L. Zhang, P. Tien, and H. B. Shu. 2008. The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity 29: 538-550.
25. Pérez de Diego, R., V. Sancho-Shimizu, L. Lorenzo, A. Puel, S. Plancoulaine, C. Picard, M. Herman, A. Cardon, A. Durandy, J. Bustamante, et al. 2010. Human TRAF3 adaptor molecule deficiency leads to impaired Toll-like receptor 3 response and susceptibility to herpes simplex encephalitis. Immunity 33: 400-411.
26. Paz, S., M. Vilasco, S. J. Werden, M. Arguello, D. Joseph-Pillai, T. Zhao, T. L. Nguyen, Q. Sun, E. F. Meurs, R. Lin, and J. Hiscott. 2011. A functional C-terminal TRAF3-binding site in MAVS participates in positive and negative regulation of the IFN antiviral response. Cell Res. 21: 895-910.
27. Ni, C. Z., G. Oganesyan, K. Welsh, X. Zhu, J. C. Reed, A. C. Satterthwait, G. Cheng, and K. R. Ely. 2004. Key molecular contacts promote recognition of the BAFF receptor by TNF receptor-associated factor 3: implications for intracellular signaling regulation. J. Immunol. 173: 7394-7400. (Pubitemid 39628178)
28. Nakhaei, P., T. Mesplede, M. Solis, Q. Sun, T. Zhao, L. Yang, T. H. Chuang, C. F. Ware, R. Lin, and J. Hiscott. 2009. The E3 ubiquitin ligase Triad3A negatively regulates the RIG-I/MAVS signaling pathway by targeting TRAF3 for degradation. PLoS Pathog. 5: e1000650.
29. Lou, X., S. Sun, W. Chen, Y. Zhou, Y. Huang, X. Liu, Y. Shan, and C. Wang. 2011. Negative feedback regulation of NF-κB action by CITED2 in the nucleus. J. Immunol. 186: 539-548.
30. Huang, Y., L. Chen, Y. Zhou, H. Liu, J. Yang, Z. Liu, and C. Wang. 2011. UXTV1 protects cells against TNF-induced apoptosis through modulating complex II formation. Mol. Biol. Cell 22: 1389-1397.
31. Sun, S., Y. Tang, X. Lou, L. Zhu, K. Yang, B. Zhang, H. Shi, and C. Wang. 2007. UXT is a novel and essential cofactor in the NF-kappaB transcriptional enhanceosome. J. Cell Biol. 178: 231-244. (Pubitemid 47076460)
32. Ni, C. Z., K. Welsh, E. Leo, C. K. Chiou, H. Wu, J. C. Reed, and K. R. Ely. 2000. Molecular basis for CD40 signaling mediated by TRAF3. Proc. Natl. Acad. Sci. USA 97: 10395-10399.
33. Jabara, H., D. Laouini, E. Tsitsikov, E. Mizoguchi, A. Bhan, E. Castigli, F. Dedeoglu, V. Pivniouk, S. Brodeur, and R. Geha. 2002. The binding site for TRAF2 and TRAF3 but not for TRAF6 is essential for CD40-mediated immunoglobulin class switching. Immunity 17: 265-276. (Pubitemid 35279548)
34. Li, C., P. S. Norris, C. Z. Ni, M. L. Havert, E. M. Chiong, B. R. Tran, E. Cabezas, J. C. Reed, A. C. Satterthwait, C. F. Ware, and K. R. Ely. 2003. Structurally distinct recognition motifs in lymphotoxin-beta receptor and CD40 for tumor necrosis factor receptor-associated factor (TRAF)-mediated signaling. J. Biol. Chem. 278: 50523-50529. (Pubitemid 37548898)
35. Ely, K. R., R. Kodandapani, and S. Wu. 2007. Protein-protein interactions in TRAF3. Adv. Exp. Med. Biol. 597: 114-121.
36. Markus, S. M., S. S. Taneja, S. K. Logan, W. Li, S. Ha, A. B. Hittelman, I. Rogatsky, and M. J. Garabedian. 2002. Identification and characterization of ART-27, a novel coactivator for the androgen receptor N terminus. Mol. Biol. Cell 13: 670-682. (Pubitemid 34165092)
37. Zhao, H., Q. Wang, H. Zhang, Q. Liu, X. Du, M. Richter, and M. I. Greene. 2005. UXT is a novel centrosomal protein essential for cell viability. Mol. Biol. Cell 16: 5857-5865. (Pubitemid 41752232)
38. Hou, F., L. Sun, H. Zheng, B. Skaug, Q. X. Jiang, and Z. J. Chen. 2011. MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell 146: 448-461.
39. You, F., H. Sun, X. Zhou, W. Sun, S. Liang, Z. Zhai, and Z. Jiang. 2009. PCBP2 mediates degradation of the adaptor MAVS via the HECT ubiquitin ligase AIP4. Nat. Immunol. 10: 1300-1308.
40. Gstaiger, M., B. Luke, D. Hess, E. J. Oakeley, C. Wirbelauer, M. Blondel, M. Vigneron, M. Peter, and W. Krek. 2003. Control of nutrient-sensitive transcription programs by the unconventional prefoldin URI. Science 302: 1208-1212. (Pubitemid 37421025)
41. Siegert, R., M. R. Leroux, C. Scheufler, F. U. Hartl, and I. Moarefi. 2000. Structure of the molecular chaperone prefoldin: unique interaction of multiple coiled coil tentacles with unfolded proteins. Cell 103: 621-632.